Hsia K, Zhao N, Chung M, Algarrahi K, Kouhsari LM, Fu M, Chen H, Singh S, Michaud DS, Jangi S. Alterations in the Fungal Microbiome in Ulcerative Colitis. Inflamm Bowel Dis. 2023 May 23:izad082. doi: 10.1093/ibd/izad082. PMID:
37221272.
Marshall A, Fai C, Han J, Yule AM, Jangi S. Rising Inpatient Utilization and Costs of Cannabis Hyperemesis Syndrome Hospitalizations in Massachusetts After Cannabis Legalization J Clin Gastroenterol. 2023 May 10. doi: 10.1097/MCG.0000000000001857. PMID: 37224284.
Zenia T, Gandhi S, Mittal A, Levy A, Weinstock J, Singh S, Jangi S. Predictors and Etiologies of Clinical Relapse Among Patients with Ulcerative Colitis in Deep Remission. J Clin Gastroenterol. 2023 Feb 8. doi: 10.1097/MCG.0000000000001834. Epub ahead of print. PMID: 36753459.
Holmer AK, Luo J, Russ KB, Park S, Yang JY, Ertem F, Dueker J, Nguyen V, Hong S, Zenger C, Axelrad JE, Sofia A, Petrov JC, Al-Bawardy B, Fudman DI, Llano E, Dailey J, Jangi S, Khakoo N, Damas OM, Barnes EL, Scott FI, Ungaro RC, Singh S; REACH-IBD (Rising Educators Academics and Clinicians Helping-IBD). Comparative Safety of Biologic Agents in Patients with Inflammatory Bowel Disease with Active or Recent Malignancy: A Multi-Center Cohort Study. Clin Gastroenterol Hepatol. 2023 Jan 12:S1542-3565(23)00029-0. doi: 10.1016/j.cgh.2023.01.002. Epub ahead of print. PMID: 36642291.
Nayantara Orekondy, Kathryn Welp, Caitlin Fai, Carter Lebares, Christina Pastan, S Jangi, 2022,ISSN 2590-0307,https://doi.org/10.1016/j.tige.2022.12.002. (Effectiveness of a Mindfulness-Based Intervention in Endoscopy Among Gastroenterology Fellows: A Pilot Study)
Jangi S. In Memoriam: Dr Joel Weinstock-A Pioneer of the Hygiene Hypothesis. Gastroenterology. 2022 Oct;163(4):785-786. doi: 10.1053/j.gastro.2022.07.026. Epub 2022 Jul 19. PMID: 35934020.
Shiv Gandhi, MD, Sara Zelman, MD, Ricardo Eduardo De Armas, MD, Christopher Hemond, MD, Alexander N Levy, MD, Siddharth Singh, MS, MD, Joshua Korzenik, MD, Sushrut Jangi, MD, Natural History of New-onset Inflammatory Bowel Disease Among Patients With Multiple Sclerosis, Inflammatory Bowel Diseases, 2022;, izac053,
https://doi.org/10.1093/ibd/izac053. 26 March, 2022.
Jangi S, Lebares C.
Scoping Mindfully. Gastrointestinal Endoscopy. 2021 Oct ; 94(4):877-878.doi: 10.1016/j.gie.2021.05.043.
Jangi S, Holmer AK, Dulai PS, Boland B, Valasek M, Jairath V, Feagan BG, Sandborn WJ, Singh S.
Spatial Evolution of Histologic and Endoscopic Healing in the Left and Right Colon in Patients With Ulcerative Colitis.Clin Gastroenterol Hepatol. 2021 Feb 6:S1542-3565(21)00108-7. doi: 10.1016/j.cgh.2021.02.007. Epub ahead of print. PMID: 33556578.
Jangi, S., Yoon, H., Dulai, P., Valasek, M., Boland, B., Jairath, V., Feagan, B., Sandborn, W. and Singh, S. (2021),
Letter: the combination of histologic remission and Mayo endoscopic score 1 as a suitable therapeutic target in ulcerative colitis—authors' reply. Aliment Pharmacol Ther, 53: 957-958. https://doi.org/10.1111/apt.16316
Risk of Relapse in Patients with Ulcerative Colitis with Persistent Endoscopic Healing: A Durable Treatment Endpoint. Journal of Crohn’s and Colitis; jjaa 184; September 2020. Jangi S, Holmer A, Dulai P, Boland B, Collins A, Pham L, Sandborn W, Singh S.
Predictors and outcomes of achieving histological remission in ulcerative colitis treated to endoscopic healing. Alimentary Pharmacology & Therapeutics. 2020 August. Jangi S, Yoon H, Dulai PS, Valasek M, Boland BS, Jairath V, Feagan BG, Sandborn WJ, Singh S.
Incremental Benefit of Achieving Endoscopic and Histologic Remission in Patients with Ulcerative Colitis: A Systematic Review and Meta-Analysis. Gastroenterology. 2020 Jun 22. Yoon H, Jangi S, Dulai PS, Boland BS, Prokop LJ, Jairath V, Feagan BG, Sandborn WJ, Singh S.
South Asian Patients With Inflammatory Bowel Disease in the United States Demonstrate More Fistulizing and Perianal Crohn Phenotype. Inflamm Bowel Dis. 2020 Mar 02. Jangi S, Ruan A, Korzenik J, de Silva P.
Diagnostic Comparison of CT Scans and Colonoscopy for Immune-Related Colitis in Ipilimumab-Treated Advanced Melanoma Patients. Cancer Immunol Res. 2017 04; 5(4):286-291.
Alterations of the human gut microbiome in multiple sclerosis. Nat Commun. 2016 06 28; 7:12015. Jangi S, Gandhi R, Cox LM, Li N, von Glehn F, Yan R, Patel B, Mazzola MA, Liu S, Glanz BL, Cook S, Tankou S, Stuart F, Melo K, Nejad P, Smith K, Topçuolu BD, Holden J, Kivisäkk P, Chitnis T, De Jager PL, Quintana FJ, Gerber GK, Bry L, Weiner HL.
The molecular basis for the immunomodulatory activities of unconjugated bilirubin. Int J Biochem Cell Biol. 2013 Dec; 45(12):2843-51. Jangi S, Otterbein L, Robson S.
Training physicians to manage obesity--back to the drawing board. N Engl J Med. 2013 Oct 10; 369(15):1389-91. Colbert JA, Jangi S.
Problems of creating bone marrow donor registries in emerging economies. BMJ. 2013 May 10; 346:f2976.
Under the medical tent at the Boston Marathon. N Engl J Med. 2013 May 23; 368(21):1953-5. Jangi S.
Facing uncertainty--dispatch from Beth Israel Medical Center, Manhattan. N Engl J Med. 2012 Dec 13; 367(24):2267-9. Jangi S.
Asymptomatic colonization by Clostridium difficile in infants: implications for disease in later life. J Pediatr Gastroenterol Nutr. 2010 Jul; 51(1):2-7. Jangi S, Lamont JT.
Organelle-specific control of intracellular transport: distinctly targeted isoforms of the regulator Klar. Mol Biol Cell. 2005 Mar; 16(3):1406-16. Guo Y, Jangi S, Welte MA. PMID: 15647372.
Sushrut Jangi, MD completed his Internal Medicine Residency at Beth Israel Deaconess Medical Center in Boston and finished his Gastroenterology Fellowship at Brigham and Women's Hospital. He also completed an additional year of specialized training in Inflammatory Bowel Disease with Dr. William Sandborn at UC San Diego.
In his free time, Dr. Jangi enjoys journalism, writing, reading, watching the Patriots, cycling, tennis and hunting for coffee.
